Text Size

Functioning Disturbance in Chronic Back Pain: Altered Muscle Metabolism

This study is currently recruiting participants.
Verified May 2012 by Oslo University Hospital
Sponsor:
Collaborator:
The Research Council of Norway
Information provided by (Responsible Party):
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01593839
First received: May 4, 2012
Last updated: May 7, 2012
Last verified: May 2012
History of Changes
  Purpose

The main objective of this study is to investigate the muscle metabolism in individuals with chronic non-specific low back pain (CNSLBP) to enhance our understanding of chronic back pain.


Condition
Chronic Non-specific Low Back Pian

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Functioning Disturbance in Chronic Back Pain: Altered Muscle Metabolism

Resource links provided by NLM:

MedlinePlus related topics: Back Pain
U.S. FDA Resources

Further study details as provided by Oslo University Hospital:

Biospecimen Retention:   Samples Without DNA

Interstitial


Estimated Enrollment: 6
Study Start Date: May 2012
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   30 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Persons referred to Hospital of rehabilitation due to chronic non-specific low back pain

Criteria

The NSCBP group:

  • At least 6 patients will be included in this study.
  • All patients referred to Vestfold Hospital Trust, Kysthospitalet, diagnosed with chronic NSCBP >3 months duration will be invited to participate in the study. The invitation will be in a written form.

Exclusion Criteria:

  • anamnesis of medical or drug abuse,
  • surgery on the musculoskeletal system of the trunk,
  • known congenital malformation of the spine or scoliosis,
  • body mass index > 27 kg/m2,
  • systemic-neurological-degenerative disease,
  • history of stroke,
  • psychiatric disorder,
  • pregnancy and abnormal blood pressure. The subjects will be asked not to use any medications except for paracetamol preparations one week before examination and instructed not to perform any back-straining exercise for 48 h prior to the study, except for ordinary daily working and/or leisure activities.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01593839

Contacts
Contact: Aage Indahl, PhD, MD (+47)33134045 aage.indahl@siv.no
Contact: Vegard Pihl Moen, PT, MSc (+47)33134097 vegard.pihl.moen@siv.no

Locations
Norway
Kysthospitalet, Vestfold Hospital Trust Recruiting
Stavern, Norway, 3290
Contact: Aage Indahl, MD, PhD     +4791765888     aage.indahl@siv.no    
Contact: Vegar Phil Moen, MS     +4792438242     Vegar.Phil.Moen@siv.no    
Sponsors and Collaborators
Oslo University Hospital
The Research Council of Norway
  More Information

No publications provided

Responsible Party: Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01593839     History of Changes
Other Study ID Numbers: 182006/V50, 08/5253 Personvernombudet RRHF
Study First Received: May 4, 2012
Last Updated: May 7, 2012
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Additional relevant MeSH terms:
Back Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 19, 2013